Clinical, surgical and histopathological characteristics of liver transplant recipients: An analysis of a large sample from Turkey

Atilla Bulur, Murat Sevmiş
{"title":"Clinical, surgical and histopathological characteristics of liver transplant recipients: An analysis of a large sample from Turkey","authors":"Atilla Bulur, Murat Sevmiş","doi":"10.4274/gulhane.galenos.2021.83803","DOIUrl":null,"url":null,"abstract":"Aims: Liver transplantation (LT) is the most effective treatment method for end-stage liver failure and acute liver failure, depending on all causes. This study aimed to examine the clinical, surgical, and histopathological characteristics of LT recipients in a referral center in Turkey. Methods: In this single-center study, demographic, clinical, laboratory, radiological, surgical, and histopathological data of LT recipients aged 18 years or over between December 2017 and February 2021 were retrospectively analyzed. All subjects were transplanted from live donors and cadavers. Results: The sample included 162 subjects [mean age: 50.1 (18-70) years;male: 64.8%. The proportion of live donor transplantation was 86.4% (n=140)]. The mean follow-up time was 20.5 months (1-39 months). The most common primary indication was hepatocellular carcinoma (n=43, 26.5%) and chronic hepatitis B virus infection-related cirrhosis (n=30, 18.5%). The most common postoperative complication was biliary complications (30.9%). One-year survival was 88.9%, two-year survival was 85.8%, and three-year survival was 83.3%. During the 3-year follow-up, the total graft loss rate was observed by 17.9%, and the mortality rate was 15.4%. Conclusions: The main goal in LT is the long-term survival of the graft and the patient. The present study showed that demographic characteristics, etiological characteristics, postoperative complications, and mortality rates among LT recipients were consistent with the results of other centers around the world.","PeriodicalId":35658,"journal":{"name":"Gulhane Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gulhane Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/gulhane.galenos.2021.83803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Liver transplantation (LT) is the most effective treatment method for end-stage liver failure and acute liver failure, depending on all causes. This study aimed to examine the clinical, surgical, and histopathological characteristics of LT recipients in a referral center in Turkey. Methods: In this single-center study, demographic, clinical, laboratory, radiological, surgical, and histopathological data of LT recipients aged 18 years or over between December 2017 and February 2021 were retrospectively analyzed. All subjects were transplanted from live donors and cadavers. Results: The sample included 162 subjects [mean age: 50.1 (18-70) years;male: 64.8%. The proportion of live donor transplantation was 86.4% (n=140)]. The mean follow-up time was 20.5 months (1-39 months). The most common primary indication was hepatocellular carcinoma (n=43, 26.5%) and chronic hepatitis B virus infection-related cirrhosis (n=30, 18.5%). The most common postoperative complication was biliary complications (30.9%). One-year survival was 88.9%, two-year survival was 85.8%, and three-year survival was 83.3%. During the 3-year follow-up, the total graft loss rate was observed by 17.9%, and the mortality rate was 15.4%. Conclusions: The main goal in LT is the long-term survival of the graft and the patient. The present study showed that demographic characteristics, etiological characteristics, postoperative complications, and mortality rates among LT recipients were consistent with the results of other centers around the world.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝移植受者的临床、手术和组织病理学特征:对土耳其大样本的分析
目的:肝移植(LT)是治疗终末期肝功能衰竭和急性肝功能衰竭最有效的方法,这取决于各种原因。本研究旨在检查土耳其转诊中心LT接受者的临床、手术和组织病理学特征。方法:在这项单中心研究中,回顾性分析了2017年12月至2021年2月期间18岁或以上LT接受者的人口统计学、临床、实验室、放射学、外科和组织病理学数据。所有受试者均来自活体捐赠者和尸体。结果:样本包括162名受试者[平均年龄:50.1(18-70)岁;男性:64.8%。活体供体移植的比例为86.4%(n=140)]。平均随访时间20.5个月(1-39个月)。最常见的原发指征是肝细胞癌(n=43,26.5%)和慢性乙型肝炎病毒感染相关的肝硬化(n=30,18.5%)。最常见的术后并发症是胆道并发症(30.9%)。一年生存率为88.9%,两年生存率为85.8%,三年存活率为83.3%。在三年随访中,总移植物丢失率为17.9%,死亡率15.4%。结论:LT的主要目标是移植物和患者的长期生存。本研究表明,LT接受者的人口统计学特征、病因特征、术后并发症和死亡率与世界其他中心的结果一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gulhane Medical Journal
Gulhane Medical Journal Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
48
期刊介绍: History of the Gulhane Medical Journal goes back beyond the second half of the nineteenth century. "Ceride-i Tıbbiye-yi Askeriye" is the first journal published by the Turkish military medical community between 1871 and 1931. This journal was published as "Askeri Tıp Mecmuası", "Askeri Sıhhiye Mecmuası","Askeri Sıhhiye Dergisi" and "GATA Bülteni" between 1921 to 1931, 1931 to 1949, 1949 to 1956 and 1956 to 1998, respectively. The journal is currently being published as "Gülhane Tıp Dergisi" ("Gulhane Medical Journal") since the September 1998 issue.
期刊最新文献
Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients? Association between plasma fluoride levels and pregnancy complications in women living in the rural and urban areas of Settat-Morocco T-cell acute lymphoblastic leukemia in an adolescent presenting with peripheral facial paralysis: A case report and literature review Colonic polyposis with underlying diffuse large B-cell lymphoma presenting with ileocolic intussusception Local anesthetic administration for frequent episodic tension-type headache in the elderly
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1